Literature DB >> 19960402

S3-guideline "helicobacter pylori and gastroduodenal ulcer disease" of the German society for digestive and metabolic diseases (DGVS) in cooperation with the German society for hygiene and microbiology, society for pediatric gastroenterology and nutrition e. V., German society for rheumatology, AWMF-registration-no. 021 / 001.

W Fischbach1, P Malfertheiner, J C Hoffmann, W Bolten, J Bornschein, O Götze, W Höhne, M Kist, S Koletzko, J Labenz, P Layer, St Miehlke, A Morgner, U Peitz, J Preiss, C Prinz, U Rosien, W Schmidt, A Schwarzer, St Suerbaum, A Timmer, G Treiber, M Vieth.   

Abstract

This guideline updates a prior consensus recommendation of the German Society for Digestive and Metabolic Diseases (DGVS) from 1996. It was developed by an interdisciplinary cooperation with representatives of the German Society for Hygiene and Microbiology, the Society for Pediatric Gastroenterology and Nutrition (GPGE), and the German Society for Rheumatology. The guideline is methodologically based on recommendations of the Association of the Scientific Medical Societies in Germany (AWMF) for providing a systematic evidence-based S 3 level consensus guideline and has also implemented grading criteria according to the GRADE (Grading of Recommendations Assessment, Development, and Evaluation) process. Clinical applicability of study results as well as specifics for Germany in terms of epidemiology, antibiotic resistance status, diagnostics, and therapy were taken into account.

Entities:  

Mesh:

Year:  2009        PMID: 19960402     DOI: 10.1055/s-0028-1109855

Source DB:  PubMed          Journal:  Z Gastroenterol        ISSN: 0044-2771            Impact factor:   2.000


  16 in total

1.  Correspondence (letter to the editor): Targeted second-line treatment.

Authors:  Jonathan Jantsch; Christian Bogdan
Journal:  Dtsch Arztebl Int       Date:  2010-07-09       Impact factor: 5.594

2.  Management of Helicobacter pylori infection in Latin America: a Delphi technique-based consensus.

Authors:  Antonio Rollan; Juan Pablo Arab; M Constanza Camargo; Roberto Candia; Paul Harris; Catterina Ferreccio; Charles S Rabkin; Juan Cristóbal Gana; Pablo Cortés; Rolando Herrero; Luisa Durán; Apolinaria García; Claudio Toledo; Alberto Espino; Nicole Lustig; Alberto Sarfatis; Catalina Figueroa; Javier Torres; Arnoldo Riquelme
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

Review 3.  Recurrent abdominal pain in childhood.

Authors:  Philip Bufler; Martina Gross; Holm H Uhlig
Journal:  Dtsch Arztebl Int       Date:  2011-04-29       Impact factor: 5.594

4.  An internet portal for the development of clinical practice guidelines.

Authors:  W J Höhne; T Karge; B Siegmund; J Preiss; J C Hoffmann; M Zeitz; U R Fölsch
Journal:  Appl Clin Inform       Date:  2010-11-24       Impact factor: 2.342

Review 5.  The Indications, Applications, and Risks of Proton Pump Inhibitors.

Authors:  Joachim Mössner
Journal:  Dtsch Arztebl Int       Date:  2016-07-11       Impact factor: 5.594

Review 6.  [Modern Helicobacter pylori therapies in times of increasing anti biotic resistance].

Authors:  Marco Berning; Susanne Krasz; Joachim Labenz; Stephan Miehlke
Journal:  Med Klin (Munich)       Date:  2010-12-07

7.  Sequential H. pylori eradication and radiation therapy with reduced dose compared to standard dose for gastric MALT lymphoma stages IE & II1E: a prospective randomized trial.

Authors:  Renate Schmelz; Stephan Miehlke; Christian Thiede; Stefan Brueckner; Monic Dawel; Matthias Kuhn; Agnes Ruskoné-Formestraux; Manfred Stolte; Christina Jentsch; Jochen Hampe; Andrea Morgner
Journal:  J Gastroenterol       Date:  2018-10-16       Impact factor: 7.527

8.  Should quinolones come first in Helicobacter pylori therapy?

Authors:  Marco Berning; Susanne Krasz; Stephan Miehlke
Journal:  Therap Adv Gastroenterol       Date:  2011-03       Impact factor: 4.409

9.  Different antibiotic susceptibility between antrum and corpus of the stomach, a possible reason for treatment failure of Helicobacter pylori infection.

Authors:  Michael Selgrad; Ina Tammer; Cosima Langner; Jan Bornschein; Julia Meißle; Arne Kandulski; Mariya Varbanova; Thomas Wex; Dirk Schlüter; Peter Malfertheiner
Journal:  World J Gastroenterol       Date:  2014-11-21       Impact factor: 5.742

10.  Clopidogrel and proton pump inhibitor (PPI) interaction: separate intake and a non-omeprazole PPI the solution?

Authors:  S Kenngott; R Olze; M Kollmer; H Bottheim; A Laner; E Holinski-Feder; M Gross
Journal:  Eur J Med Res       Date:  2010-05-18       Impact factor: 2.175

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.